Background: Cases of primary renal lymphoma (PRL) are quite rare and are often mistaken for renal cell carcinoma. Purpose: To determine the multislice computed tomography (MSCT) and magnetic resonance imaging (MRI) characteristics of PRL. Materials and Methods: Twenty-three patients with PRL were identified by CT and MRI, and their tumor characteristics were assessed. Results: Tumors exhibited single or multifocal nodules (n ¼ 19) and diffuse renal enlargement (n ¼ 4). Twenty-two tumors exhibited an infiltrative appearance. There was no evidence of calcification in any of the cases. Twenty-one tumors displaced or wrapped around abdominal vessels rather than encasing them. Enlarged retroperitoneal nodes were observed in three cases. Neither extension into the venous system nor distant metastasis was found. Tumor enhancement was of low attenuation compared with that of normal renal cortex and medulla (P < 0.05). PRL was isointense on T1-weighted imaging, slightly hypointense on T2-weighted imaging and hyperintense on diffusion-weighted imaging. Twenty-two patients exhibited biopsy-confirmed PRN. There were four, 12, and seven cases of low-grade, intermediate-grade, and high-grade tumors, respectively. Patient were followed up over 16 to 166 months. Six patients died within three years and five patients died within five years. Conclusion: Infiltrative appearance and tumor displacement or extension around abdominal vessels rather than vessel encasement are common findings on CT or MRI imaging and may suggest a diagnosis of PRL.
Introduction
Primary renal lymphoma (PRL) is a lymphoma without evidence of systemic involvement beyond the kidney (1) . Fewer than 200 cases of PRL, including both Hodgkin's disease and non-Hodgkin's lymphoma, have been described. Common symptoms of PRL include flank or abdominal pain, hematuria, fever, weight loss, hypertension, renal insufficiency (2) , and acute renal failure. In PRL, dissemination to extrarenal sites is common and confers a poor prognosis.
Accurate diagnosis is critical because modern radiochemotherapy has improved survival and renal function in PRL (3, 4) , whereas renal cell carcinoma (RCC) is typically managed by surgery or ablation. Early diagnosis and proper management results in a favorable outcome. Therefore, further clarification and validation of the imaging features of PRL are needed. In this study, we retrospectively investigated the CT and MRI findings of 23 cases of PRL. Our purpose was to characterize the imaging features of PRL.
Material and Methods

Patients
This study was approved by the Institutional Research Ethics Committee. A retrospective search of pathology records, picture archives and communications system identified 23 patients with PRL who were treated at our hospital. Details concerning patient age, sex, tumor size, surgical or biopsy confirmation, metastasis, and clinical symptoms were recorded.
CT and MRI techniques
Twenty-three patients underwent CT examinations, and nine patients also underwent MRI. All exams were performed on one of several multidisciplinary CT (MDCT) scanners (Somatom Definition, Siemens AG, Medical Solutions, Forchheim, Germany; Brilliance 64, Philips Medical Systems, Best, The Netherlands; Light Speed VCT, GE Healthcare, Milwaukee, WI, USA). Abdominal unenhanced CT scans and contrast-enhanced CT scans were performed on 23 patients. Parameters included the following: detector collimation of 64 Â 0.6 mm, gantry rotation time of 0.5 s, pitch of 1.4, tube voltage of 120 kVp, and abdominal reference tube current of 230 mAs. All images were reconstructed from the contrast-enhanced MDCT scan with 0.75 mm slice thickness and 0.5 mm reconstruction increment. Contrast-enhanced CT scans were started by an injection of a 80-100 mL bolus of iopromide (300 mg/mL, Bayer Pharmaceuticals, Berlin, Germany) followed by 40 mL of saline solution into an antecubital vein via an 18-gauge catheter (injection rate 5 mL/s). The enhanced CT scans were performed at the 20 s arterial phase (renal cortex phase, n ¼ 23), the 65 s venous phase (renal cortico-medullary phase, n ¼ 23), and the 240 s excretory phase (delayed phase, n ¼ 23).
MRI was performed using a 3.0T scanner (Vision or Symphony, Siemens Medical Solutions, Iselin, NJ, USA; or Excite Twin Speed, GE Healthcare, Waukesha, WI, USA) on nine patients. All sequences were acquired with anterior and posterior saturation bands. Axial T1-weighted (T1W) and T2-weighted (T2W) MR images were obtained during breath-hold. The transverse planes covered the entire area of the kidneys. The following sequences were obtained: (a) coronal T2W half Fourier single-shot fast spin echo; (b) axial dual-echo T1W in-phase and opposedphase gradient echo; and (c) coronal and sagittal three-dimensional (3D) frequency-selective fatsaturated T1W spoiled gradient echo. Subsequently, diffusion-weighted imaging (DWI, b ¼ 1000) scans were acquired.
Pathologic examination
Pathological specimens were observed by light microscopy and immunohistochemical analysis. Twenty-two patients were confirmed to have PRN by biopsy and one patient was confirmed to have PRN by surgery.
Imaging analysis and statistics
Two genitourinary radiologists analyzed the images together in a process that resulted in a consensus interpretation. Each patient underwent preoperative MDCT examination. The imaging parameters included tumor size, imaging pattern, calcification, cystic or necrotic component, displaced or wrapped vessels, lymphadenopathy, metastasis, and tumor attenuation or signal on an unenhanced CT or MRI scan. The degree of enhancement (Hounsfield unit [HU]) on different phases of the enhanced CT scans was thereafter assessed.
Diagnostic criteria for PRL were as follows: (i) lymphomatous renal infiltration; (ii) non-obstructive unilateral or bilateral kidney enlargement; and (iii) no extrarenal localization at the time of diagnosis.
Infiltrative growth was characterized by lack of clear circumscriptions. However, expansive growth was defined as well-marginated, bulging tumor circumscriptions that displaced the normal renal parenchyma.
The measured tumor area (the region of interest [ROI]) was at the center of the tumor mass to avoid partial volume effects; however, if present, intratumoral calcification and cystic components were avoided. The normal renal cortex and medulla were measured in uninvolved unilateral renal cortex and medulla. ROIs of 10 mL were measured three times for each phase and the mean value was used.
Statistical analysis
Statistical analyses used SPSS17.0 statistical software (SPSS Inc., Chicago, IL, USA). Data are expressed as the mean AE sd and count data are expressed as percentages. Numeric data are expressed as the mean AE sd, and categorical data are expressed as percentages. Evaluated characteristics were compared using analysis of variance (ANOVA). P values < 0.05 were considered statistically significant.
Results
Clinical, CT, and MRI characteristics
Among the 23 cases of PRL, the presentation ages were in the range of 27-76 years. The average age at presentation was 53.6 AE 7.9 years. The study included 16 men and seven women. Fifteen cases of PRL were located in the left kidney and the remaining eight cases localized to the right kidney. The typical presentation symptom was flank or abdominal pain, which was reported in 19 cases. Hematuria was reported in eight cases. Thirteen cases with detailed clinical histories available clearly documented hypertension (blood pressure 136.7 AE 8.1/ 95.3 AE 7.8). Weight loss was reported in 11 cases.
A laboratory workup revealed a white blood cell count of 6.3 AE 2.6 Â 10 3 cells/mm 3 (normal 4-10 Â 10 3 cells/mm 3 ). Blood urea nitrogen and serum creatinine values were 39.3 AE 5.9 mg/dL (normal 7-22 mg/dL) and 2.34 AE 0.61 mg/dL (normal 0.6-1.4 mg/dL), respectively. In addition, serum calcium was elevated to 16.2 AE 4.3 mg/dL (normal 8.5-10.5 mg/dL). All other blood chemistries, including liver function tests, were within normal limits.
Twenty-one patients underwent non-contrast CT examination of the chest and pelvis, which revealed several pulmonary nodules that were too small to be characterized.
A bone marrow biopsy was performed in 21 patients and revealed no morphologic involvement of lymphoma.
Tumors (mean diameter 7.8 AE 3.2 cm) exhibited single or multifocal nodules ( Figs. 1-4 ; n ¼ 19) and diffuse renal enlargement (n ¼ 4). Tumors exhibited an infiltrative appearance ( Figs. 1-4 ; n ¼ 22, 95.6%) with poorly defined margins ( Figs. 1-4 ; n ¼ 23, 100%). There was no evidence of calcification in any of the cases. Cystic components within the tumor and hydronephrosis were observed in three and seven cases, respectively. Twenty-one tumors displaced abdominal vessels rather than encasing them (91.3%). Enlarged retroperitoneal nodes were observed in three cases (13.0%). Neither extension into the venous system nor distant metastases were found in any of the cases. Tumor attenuation was less than or equal to that of the renal cortex or medulla on unenhanced CT (Table 1 , P > 0.05); after IV contrast administration, 100% of the tumors exhibited low attenuation relative to the renal cortex and medulla (Table 1 , P < 0.05). PRL tumors were isointense on T1W imaging, slightly hypointense on T2W imaging (Figs. 1c, 3c and e), and slightly hyperintense on DWI (Fig. 3d) . The mean ADC values of PRL were 0.72 Â 10 À3 mm 2 /s.
Microscopic findings
Microscopic analysis revealed diffuse proliferation of atypical cells possessing cleaved nuclei and prominent nucleoli (Fig. 1d) . Hypercellularity (n ¼ 23) with a uniform population of malignant lymphocytes was observed (Fig. 2c) . Numerous apoptotic cells were also noted, a finding compatible with a high-grade phenotype. Immunochemistry demonstrated that 23 of the cases were positive for leucocyte common antigens (n ¼ 20), CD20 ( Fig. 4c ; n ¼ 21) and CD79a (n ¼ 17).
Therapy and follow-up
In this study, the numbers of low-grade, intermediategrade, and high-grade tumors were four, 12, and seven, respectively. Twenty-two patients underwent chemotherapy (cyclophosphamide 1.0 g/dL, doxorubicin 100 mg/dL, vincristine 2 mg/dL, and prednisone 100 mg/dL-5, 4-8 cycles), and only one patient underwent surgery. Twenty-three patients were available for follow-up for 16-166 months. Six patients died within three years and five patients died within five years.
Discussion PRL is very rare and is often mistaken clinically for RCC (5) . PRL is thought to originate in the lymph nodes of the renal sinus or in the lymphatic network of the renal capsule and manifests as focal masses (solitary or multiple), large infiltrative lesions engulfing the kidney, or diffuse bilaterally enlarged kidneys. Accurate diagnosis of PRL is critical because modern radiochemotherapy has improved survival and renal function. However, there is a relative dearth of imaging characterization for PRL. Stallone (6) proposed three rigid diagnostic criteria for PRL, which remain in use: (i) lymphomatous renal infiltration; (ii) non-obstructive unilateral or bilateral kidney enlargement; and (iii) no extrarenal localization at the time of diagnosis. According to these strict diagnostic criteria, only approximately 200 cases of PRL have been reported in the English literature to date.
PRL is typically a hypovascular tumor, unlike the much more common hypervascular (7) clear cell types of RCC, oncocytoma, and angiomyolipoma. In our study, PRL tumor enhancement was lower than the enhancement of the normal renal cortex and medulla in all enhanced phases (P < 0.001). Although their incidence is quite low, the papillary and chromophobe subtypes of RCC and renal sarcoma present as hypovascular masses. Papillary RCCs may be multifocal and bilateral, tend to be less than 2 cm in size at diagnosis and are less enhanced. Chromophobe RCCs may exhibit a spoke-like pattern in some cases (8) . Mucinous tubular and spindle cell carcinoma tends to be solitary, to exhibit poorly defined margins (9) , and to be less enhanced.
In our MRI cases, tumors exhibited lower signal intensity than normal cortex with T1W sequences and were relatively hypointense on T2W sequences, which is thought to be due to lymphadenitis (10) ; this appearance is distinct from many other renal tumors, including clear cell RCCs, some cystic renal tumors, and cysts, which appear hyperintense on T2W imaging (11) . In our limited experience, PRL tends to exhibit restricted diffusion on DWI. The imaging features of PRL on DW sequences have not been well established and require further clarification. In two separate studies, the mean ADC values of normal renal parenchyma, clear cell RCC, papillary RCC, and chromophobe RCC were PRLs exhibited an infiltrative appearance with poorly defined margins. However, despite being aggressive tumors, PRLs only rarely involve the inferior vena cava (7); this characteristic of PRL can help differentiate it from RCC. In our study, there was no evidence of extension into the venous system in any case of PRL, which is consistent with the findings of previous reports (14) . This pattern is also dissimilar from most RCCs, which grow by radial expansion and displacement of the normal parenchyma, focal bulging of the renal contour, and pseudocapsule formation. In addition to PRL, there are other uncommon renal tumors that are typically infiltrative in nature, e.g. renal medullary carcinoma and collecting duct carcinoma. Central location and an infiltrative growth pattern invading the renal sinus are typical features of renal medullary carcinoma (15) . Furthermore, caliectasis without pelviectasis and tumor encasement of the renal pelvis are also described. Medullary involvement and an infiltrative appearance are common findings of collecting duct carcinoma (16) .
Perlman (17) reported that intratumor calcification is suggestive of RCC subtypes. However, there was no evidence of calcification in any case of PRL in our study. Twenty-one tumors displaced or extended around the abdominal vessels rather than encasing them (91.3%). A cystic appearance is also highly unusual in PRL. Some lesions may contain large low-attenuation areas, perhaps related to necrosis, particularly during chemotherapy. In our study, only three cases exhibited mild cystic components. These features can help to differentiate PRL from more common renal tumors with cystic components and calcifications, including RCC. RCCs greater than 3 cm in size often contain intratumoral necrosis, hemorrhage, cystic components, and calcifications and are usually of the clear cell subtype.
In our study, 82.6% of the PRL tumors exhibited single or multifocal nodules. The differential diagnosis of single or multifocal renal solid masses can include clear cell carcinoma (18) , papillary carcinoma (19) , angiomyolipoma with minimal fat, oncocytoma, and Wilms' tumor. Clear RCCs larger than 3 cm typically exhibit evidence of intratumoral necrosis, hemorrhage, cystic components, and calcifications (20) . Papillary RCCs are often homogeneous when small, but when large and/or poorly differentiated, papillary RCCs often exhibit necrosis and cystic changes and may appear heterogeneous, similar to PRL (21) . Renal abscesses and infarcts may also present as multifocal renal lesions, but clinical correlation is usually helpful.
In our study, 17.4% of the PRL tumors exhibited diffuse renal enlargement. The differential diagnosis of diffuse renal enlargement can include pyelonephritis (22) . In cases of pyelonephritis, multiple areas can be readily affected; in most cases, the lesions are well-defined, wedge-shaped areas with their bases at the periphery and their apexes towards the renal sinus (23) , with the renal parenchyma sometimes exhibiting a striated appearance.
Recent studies (24) indicate a sensitivity and specificity of 90-100% in diagnosing renal tumors. The diagnosis of PRL usually requires biopsy in most cases because imaging findings are not specific and because pathologic analysis drives specific therapies and predicts prognosis. In our study, 22 patients were confirmed to have PRN by biopsy and avoided unnecessary surgery.
The treatment of PRL is dependent on the grade of the tumor. Earlier reports (25) have suggested that cases other than the indolent type of marginal zone lymphoma exhibit poor prognoses with a median survival of less than one year. Low-grade PRL can be treated effectively with single-agent rituximab, surgical intervention, or radiation. Patients who present with intermediate-grade or high-grade tumors should not undergo surgical intervention and should be treated with systemic therapy. High-grade tumors tend to exhibit extensive involvement in regional tissues, organs, and vasculature. In these cases, surgical intervention would prove to be detrimental, with an increased risk of morbidity and mortality. In our study, 22 patients underwent chemotherapy (4-8 cycles), and 23 patients were followed from 16 months to 166 months. Six patients died within three years and five patients died within five years.
One limitation of our study is its retrospective nature. Furthermore, our relatively small study population precludes any definitive conclusions regarding the imaging characteristics of this rare tumor. Therefore, further multicenter cooperation on the radiological diagnosis of PRL is required.
In conclusion, PRL exhibits variable imaging features and may mimic RCC. Diagnosis may be established with biopsy of tumor. Proper treatment and early intervention have been documented to correlate with improved outcomes. Although aggressive, PRL responds to chemotherapy, and improvements in renal function occur rapidly after the onset of therapy. CT or MRI findings that support the diagnosis of PRL include an infiltrative appearance and displaced rather than encased abdominal vessels.
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